Remove keyword safety-profile
article thumbnail

Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges

Roots Analysis

As a starting point, the information on terminated, suspended and withdrawn trials was collated from clinicaltrials.gov and PubMed using relevant search keywords. By identifying and addressing the specific issues that have led to drug failures, developers are working to improve the efficacy and safety of NAMPT inhibitors.

FDA 40